ZEABRUYO Trademark

Trademark Overview


On Wednesday, November 4, 2020, a trademark application was filed for ZEABRUYO with the United States Patent and Trademark Office. The USPTO has given the ZEABRUYO trademark a serial number of 90299205. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 12, 2024. This trademark is owned by Eli Lilly and Company. The ZEABRUYO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases
zeabruyo

General Information


Serial Number90299205
Word MarkZEABRUYO
Filing DateWednesday, November 4, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 11, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 5, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Saturday, November 7, 2020NEW APPLICATION ENTERED
Tuesday, January 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 6, 2021ASSIGNED TO EXAMINER
Tuesday, April 6, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 21, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 11, 2021PUBLISHED FOR OPPOSITION
Tuesday, May 11, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 6, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 8, 2021SOU TEAS EXTENSION RECEIVED
Monday, November 8, 2021SOU EXTENSION 1 FILED
Tuesday, November 16, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 16, 2021SOU EXTENSION 1 GRANTED
Wednesday, November 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 3, 2022SOU TEAS EXTENSION RECEIVED
Friday, June 3, 2022SOU EXTENSION 2 FILED
Friday, June 3, 2022SOU EXTENSION 2 GRANTED
Tuesday, June 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 9, 2022SOU TEAS EXTENSION RECEIVED
Friday, December 9, 2022SOU EXTENSION 3 FILED
Friday, December 9, 2022SOU EXTENSION 3 GRANTED
Tuesday, December 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 1, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 1, 2023SOU EXTENSION 4 FILED
Thursday, June 1, 2023SOU EXTENSION 4 GRANTED
Saturday, June 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 4, 2023SOU TEAS EXTENSION RECEIVED
Monday, August 12, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, August 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, December 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 4, 2023SOU EXTENSION 5 FILED
Tuesday, December 5, 2023SOU EXTENSION 5 GRANTED